MedStart Psychiatry · Services

Bipolar
Disorder

Evidence-Based Assessment and Individualized Mood Stabilization

Bipolar disorder is one of the most treatable — and most commonly misdiagnosed — conditions in psychiatry. With the right evaluation and a personalized plan, meaningful stability is achievable.

2–4%
global lifetime prevalence across all bipolar spectrum diagnoses
9 yrs
average delay from first episode to accurate bipolar diagnosis
~20
typical age of onset; heritability approximately 70%
Schedule an Evaluation

"The most important first step in bipolar disorder is getting the diagnosis right. Depression that doesn't fully respond to antidepressants, or that keeps coming back — these are signals worth investigating carefully."

The Condition

What is bipolar disorder — and what isn't it?

Bipolar disorder is characterized by alternating episodes of elevated mood (mania or hypomania) and depression. It is not mood instability from stress, not emotional sensitivity, and not simply being "up and down." It is a neurobiological condition with a clear pattern — and with that clarity comes an evidence-based path to treatment.

Bipolar I

At Least One Manic Episode

Mania lasting ≥1 week with elevated or irritable mood and significant functional impairment. Depressive episodes are typical but not required for diagnosis. Psychotic symptoms occur in up to 75% of manic episodes.

Bipolar II

Hypomania + Major Depression

At least one hypomanic episode (≥4 days, less severe than mania) plus at least one major depressive episode. No history of full mania. Often mistaken for recurrent unipolar depression.

Cyclothymia

Chronic Mood Fluctuation

Chronic fluctuating hypomanic and depressive symptoms for ≥2 years that do not meet the full criteria for either a manic or major depressive episode.

Other Specified

Bipolar-Like Presentations

Bipolar-like symptoms that cause clinically significant impairment but do not meet full criteria for the above subtypes. This category is clinically relevant and should not be dismissed.

Clinical Presentation

What episodes look like

The two poles of bipolar disorder look and feel very different — and one tends to dominate more than the other. Patients spend approximately half their symptomatic time in depression, not mania, which is why the condition is so frequently mistaken for unipolar depression.

Manic / Hypomanic Symptoms
Elevated or irritable mood — distinct from the person's baseline
Grandiosity — inflated self-esteem or unrealistic sense of ability
Decreased need for sleep without feeling tired
Pressured speech — rapid, difficult to interrupt
Racing thoughts and subjective mental acceleration
Distractibility and difficulty maintaining focus
Increased goal-directed activity — new projects, business ideas, plans
Risky behaviors — spending, sexual behavior, impulsive decisions
Depressive Symptoms
Persistent low mood — may be indistinguishable from unipolar depression on one assessment
Hypersomnia — sleeping excessively (atypical feature suggesting bipolarity)
Hyperphagia — increased appetite or carbohydrate craving
Psychomotor slowing — visible slowing of thought and movement
Anhedonia — inability to feel pleasure from previously enjoyable activities
Hopelessness — often severe; suicide risk is significantly elevated
Cognitive difficulties — concentration, memory, and executive function
Diagnostic Challenges

Why bipolar disorder is so often missed

The average delay from a patient's first depressive episode to a correct bipolar diagnosis is approximately 9 years. During that time, patients are often treated for unipolar depression alone — and antidepressant monotherapy in bipolar disorder can destabilize mood, trigger hypomania or mania, or increase cycle frequency.

Clinical Signals That May Suggest Bipolarity

Early age of onset (teens or early twenties) for the first depressive episode
Family history of bipolar disorder or significant mood instability
Atypical depressive features — hypersomnia, hyperphagia, leaden paralysis
Psychotic features during depressive episodes
Antidepressant-induced hypomania or mood cycling
Multiple prior antidepressant trials with limited or short-lived response
Treatment — Pharmacology

Evidence-based pharmacological management

Bipolar disorder requires a different approach to medication than unipolar depression. Mood stabilization — not antidepressant monotherapy — is the foundation of effective pharmacological management.

Gold Standard
Lithium

Lithium remains the most well-studied mood stabilizer with demonstrated antimanic, antidepressant, and anti-suicide properties — a rare combination not replicated by other agents. It is the benchmark against which other treatments are measured.

Reduces mania, depression, and suicide risk
Effective in acute and maintenance phases
Requires regular monitoring of serum levels, thyroid, and kidney function
Effective for Mania
Antipsychotics

Second-generation antipsychotics are effective for acute mania and are frequently used in combination with mood stabilizers. Fewer agents have demonstrated efficacy in bipolar depression specifically.

Quetiapine — one of the few with evidence in bipolar depression
Olanzapine and aripiprazole — effective for acute mania
Often combined with a primary mood stabilizer
Anticonvulsants
Mood-Stabilizing Anticonvulsants

Several anticonvulsant medications have demonstrated efficacy in bipolar disorder, with phase-specific profiles that guide their use:

Divalproex (valproate) — effective for acute mania; often used when lithium is not tolerated
Carbamazepine — effective for acute mania, particularly mixed features
Lamotrigine — effective for treating and preventing bipolar depression; not effective for acute mania
Use With Caution
Antidepressants

Antidepressants are widely prescribed in clinical practice but carry important limitations in bipolar disorder that require honest clinical discussion:

Limited evidence for efficacy compared with mood stabilizers
Risk of triggering hypomania, mania, or rapid cycling — especially in maintenance
If used, always in combination with an established mood stabilizer
Beyond Medication

Non-pharmacological approaches that work

A systematic review and network meta-analysis of 39 randomized controlled trials found that manualized psychotherapies significantly reduced recurrence rates compared with treatment as usual. These are evidence-based adjuncts — not alternatives to medication — but they substantially improve outcomes.

Strong Evidence
CBT & Psychoeducation

Cognitive Behavioral Therapy (CBT) — A meta-analysis of 19 RCTs found adjunctive CBT associated with fewer depressive symptoms, fewer relapses, and improved functioning.

Psychoeducation (≥6 sessions) — Documented lower relapse rates, longer time to recurrence, reduced symptoms, and improved medication adherence. Group-based formats show strong results.

Relapse Prevention
FFT & IPSRT

Family-Focused Therapy (FFT) — Reduces depressive symptoms, relapses, hospitalization risk, and improves medication adherence by working with the patient's support system.

Interpersonal and Social Rhythm Therapy (IPSRT) — Stabilizes circadian rhythms and reduces interpersonal stress. Normalizing daily routines and sleep-wake cycles is a core protective factor.

Lifestyle & Chronotherapy
Sleep, Exercise, Light, and Daily Rhythm
Exercise — Significantly improves depression, anxiety, and mania symptoms. Recommended protocol: ≥12 weeks, 2–3 sessions/week, ≤90 minutes per session
Sleep hygiene and circadian regulation — Sleep interventions show significant improvement in depressive symptoms. Normalizing sleep-wake schedules is central to IPSRT and recommended across all major guidelines
Bright Light Therapy (BLT) — A meta-analysis of 7 RCTs found significant improvement in bipolar depression symptoms. 30 minutes/day, morning or midday preferred. Clinical response typically within 1–2 weeks
ECT (Electroconvulsive Therapy) — Meta-analytic response rate of 77% for severe or treatment-resistant bipolar depression. Also effective for severe mania refractory to pharmacotherapy
Clinical Insight

Getting the diagnosis right changes everything

The most important step in managing bipolar disorder is accurate diagnosis. Because depressive episodes dominate the longitudinal course, most patients first present — and are treated — as unipolar depression. Features that suggest bipolarity are often present but not asked about. A comprehensive psychiatric evaluation that specifically explores mood history, episode patterns, family history, and past treatment responses is the foundation for a care plan that actually works.

Prognosis & Comorbidity

Living with bipolar disorder — the full picture

Bipolar disorder is associated with a loss of 10–20 potential years of life, driven primarily by cardiovascular disease and suicide — not the condition itself, but the medical and psychiatric comorbidities that often go undertreated alongside it. This makes comprehensive, whole-person care essential.

Common comorbidities that require attention alongside mood management:

Anxiety Disorders Substance Use Disorders ADHD Cardiovascular Disease Sleep Disorders Metabolic Conditions

Accurate diagnosis is the first step to stability

If you have been treated for depression and haven't found lasting improvement, or if mood instability has been a recurring theme in your life — a comprehensive psychiatric evaluation can provide clarity, direction, and a plan built around your actual diagnosis.

Insurance: Currently accepting Tricare West. Additional plans coming soon. Cash-pay welcome — superbill provided upon request.

Schedule an Evaluation

Telehealth · Arizona · English & Polish · New patients typically seen within 1–3 days